Weaver John J, Natarajan Niranjana, Shaw Dennis W W, Apkon Susan D, Koo Kevin S H, Shivaram Giri M, Monroe Eric J
Department of Radiology, Section of Interventional Radiology, Seattle Children's Hospital, University of Washington, 4800 Sand Point Way NE, M/S R-5417, Seattle, WA, 98105, USA.
Department of Neurology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Pediatr Radiol. 2018 Mar;48(3):392-397. doi: 10.1007/s00247-017-4031-6. Epub 2017 Nov 13.
Nusinersen, the only treatment approved by the United States Food and Drug Administration for spinal muscular atrophy (SMA), is delivered intrathecally. Many children with SMA have extensive spinal instrumentation and deformities, often precluding the use of standard approaches for gaining intrathecal access. Furthermore the anatomical distortion that often occurs with rotoscoliosis can complicate the use of fluoroscopic guidance. Compared to fluoroscopy, CT affords superior guidance for complex needle placements. This opens up alternatives to the posterior (interlaminar) technique, including transforaminal and caudal approaches.
This study describes the early results of technical success, complications and radiation dose of intrathecal delivery of nusinersen using cone-beam CT guidance with two-axis fluoroscopic navigational overlay.
We conducted a retrospective review of 15 consecutive nusinersen injections performed in four children with SMA and extensive spinal hardware precluding standard posterior lumbar puncture techniques. These children were treated using transforaminal thecal access employing cone-beam CT with navigational overlay. We analyzed results including technical success, complications and total fluoroscopy time.
All procedures were technically successful. No major complications and one minor complication were reported; the minor complication was a post-procedural neuropathic headache that was attributed to procedural positioning and was treated successfully with gabapentin. The average procedural fluoroscopy time and air kerma were 1.9 min and 55.8 mGy, respectively.
Cone-beam CT guidance with two-axis navigational overlay is a safe, effective method for gaining transforaminal intrathecal access in children with spinal abnormalities and hardware precluding the use of standard techniques.
诺西那生钠是美国食品药品监督管理局批准的唯一用于治疗脊髓性肌萎缩症(SMA)的药物,需鞘内注射给药。许多患有SMA的儿童有广泛的脊柱内固定和畸形,这常常排除了使用标准方法进行鞘内穿刺的可能性。此外,脊柱侧弯常出现的解剖结构变形会使荧光透视引导的使用变得复杂。与荧光透视相比,CT在复杂的穿刺针放置方面提供了更好的引导。这为后入路(椎板间)技术提供了替代方法,包括经椎间孔和尾侧入路。
本研究描述了使用双轴荧光透视导航叠加的锥形束CT引导鞘内注射诺西那生钠的技术成功率、并发症和辐射剂量的早期结果。
我们对4例患有SMA且有广泛脊柱内固定装置而排除标准后路腰椎穿刺技术的儿童连续进行的15次诺西那生钠注射进行了回顾性研究。这些儿童采用经椎间孔鞘内穿刺入路,使用带有导航叠加的锥形束CT进行治疗。我们分析了包括技术成功率、并发症和总荧光透视时间在内的结果。
所有操作在技术上均获成功。未报告重大并发症,仅报告了1例轻微并发症;该轻微并发症为术后神经性头痛,归因于操作时的体位,使用加巴喷丁成功治疗。平均操作荧光透视时间和气比释动能分别为1.9分钟和55.8毫戈瑞。
双轴导航叠加的锥形束CT引导是一种安全、有效的方法,可用于有脊柱异常和内固定装置而无法使用标准技术的儿童进行经椎间孔鞘内穿刺。